Avita Medical (RCEL) Stock Price, News & Analysis

Company Overview

Avita Medical, Inc. (NASDAQ: RCEL) is a regenerative medicine company focused on developing and commercializing therapies that use a patient’s own cells to help restore damaged skin and tissue. Its lead product is the RECELL System, an autologous cell-harvesting device designed to prepare a suspension of a patient’s skin cells at the point of care for application to wounds.

RECELL is used in the treatment of certain thermal burn wounds and other skin injuries. The system is intended to support wound healing and may reduce the amount of donor skin required for grafting by enabling clinicians to create a cell suspension from a small sample of the patient’s healthy skin. Avita Medical continues to pursue additional clinical and regulatory applications for its regenerative skin-repair technology.

The company serves healthcare providers and burn-treatment centers, primarily in the United States, while also maintaining international operations and commercial interests. Avita Medical traces its origins to an Australian biotechnology business and has undergone several corporate and brand changes as it developed its regenerative medicine platform. Its corporate headquarters are in Valencia, California.

Key Stats

• Today's Range: $15.24 to $16.60
• 50-Day Range: $9.86 to $16.71
• 52-Week Range: $3.22 to $16.90
• Volume: 596,618 shs
• Average Volume: 409,642 shs
• Market Capitalization: $481.71 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.20
• Consensus Rating: Moderate Buy

Avita Medical Stock Analysis - MarketRank™

Avita Medical scored higher than 28% of companies evaluated by MarketBeat, and ranked 788th out of 896 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Avita Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.

Downside Risk

Avita Medical has a consensus price target of $12.20, representing about 22.0% downside from its current price of $15.65.

Amount of Analyst Coverage

Avita Medical has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Avita Medical are expected to grow in the coming year, from ($0.98) to ($0.52) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Avita Medical is -10.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Avita Medical is -10.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.43% of the float of Avita Medical has been sold short.

Short Interest Ratio / Days to Cover

Avita Medical has a short interest ratio ("days to cover") of 7.63.

Change versus previous month

Short interest in Avita Medical has recently decreased by 1.80%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Avita Medical does not currently pay a dividend.

Dividend Growth

Avita Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 0.55

News Sentiment

Avita Medical has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Avita Medical this week, compared to 3 articles on an average week.

Search Interest

2 people have searched for RCEL on MarketBeat in the last 30 days.

MarketBeat Follows

2 people have added Avita Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Avita Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.24% of the stock of Avita Medical is held by insiders.

Percentage Held by Institutions

27.66% of the stock of Avita Medical is held by institutions.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/31/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:RCEL
• CIK: 1762303
• Web: www.avitamedical.com
• Phone: (833) 462-8482
• Fax: N/A
• Employees: 226
• Year Founded: 1992

Price Target and Rating

• Average Price Target for Avita Medical: $12.20
• High Price Target: $15.00
• Low Price Target: $10.00
• Potential Upside/Downside: -22.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.57
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.44)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$48.59 million
• Net Margins: -56.96%
• Pretax Margin: -56.94%
• Return on Equity: N/A
• Return on Assets: -78.53%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.41
• Quick Ratio: 0.34

Sales & Book Value

• Annual Sales: $71.61 million
• Price / Sales: 6.73
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.55) per share
• Price / Book: -28.45

Miscellaneous

• Outstanding Shares: 30,780,000
• Free Float: 30,088,000
• Market Cap: $481.71 million
• Optionable: Optionable
• Beta: 1.99